Literature DB >> 12551947

Both Max and TFE3 cooperate with Smad proteins to bind the plasminogen activator inhibitor-1 promoter, but they have opposite effects on transcriptional activity.

Asya V Grinberg1, Tom Kerppola.   

Abstract

Transforming growth factor (TGF)-beta regulates gene expression in large part through combinatorial interactions between members of the Smad family and other transcription factors. The basic helix-loop-helix leucine zipper (bHLHZIP) protein TFE3 and Smad3 synergistically activate transcription of the plasminogen activator inhibitor-1 (PAI-1) as well as other genes. We investigated interactions among different bHLHZIP and Smad family proteins. TFE3, TFEB, and Max associated with Smad3 and Smad4 in the absence of DNA and at the PE2.1 element of the PAI-1 promoter. These interactions were mediated by the leucine zipper and MH1 regions of the respective proteins. No interactions were observed with the E47 bHLH family protein. Chimeric proteins, in which leucine zippers from bHLHZIP or bZIP proteins were fused to heterologous bHLH domains, associated with Smad proteins both in the absence of DNA and at the PE2.1 element. The kinetics of bHLHZIP and Smad protein binding at the PE2.1 element were examined using surface plasmon resonance analysis. TFE3 exhibited cooperative DNA binding with Smad proteins, whereas no cooperativity was observed between E47 and Smads. Max inhibited transcription activation by Smad3 and TGF-beta at the PAI-1 promoter, whereas TFE3 and TFEB stimulated transcription activation. These results suggest that Smad family proteins can interact with several bHLHZIP proteins, resulting in different transcriptional outcomes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12551947     DOI: 10.1074/jbc.M211734200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Synergistic transcription activation by Maf and Sox and their subnuclear localization are disrupted by a mutation in Maf that causes cataract.

Authors:  Nirmala Rajaram; Tom K Kerppola
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

2.  JunB mediates enhancer/promoter activity of COL1A2 following TGF-beta induction.

Authors:  Markella Ponticos; Clare Harvey; Tetsuro Ikeda; David Abraham; George Bou-Gharios
Journal:  Nucleic Acids Res       Date:  2009-06-26       Impact factor: 16.971

3.  Increased cell migration and plasticity in Nrf2-deficient cancer cell lines.

Authors:  G Rachakonda; K R Sekhar; D Jowhar; P C Samson; J P Wikswo; R D Beauchamp; P K Datta; M L Freeman
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

Review 4.  Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.

Authors:  Rohan Samarakoon; Paul J Higgins
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

5.  Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by Sp1 and Smad2 transacting factors.

Authors:  Polina Sysa; James J Potter; Xiaopu Liu; Esteban Mezey
Journal:  DNA Cell Biol       Date:  2009-09       Impact factor: 3.311

6.  The TGF-beta1/upstream stimulatory factor-regulated PAI-1 gene: potential involvement and a therapeutic target in Alzheimer's disease.

Authors:  Paul J Higgins
Journal:  J Biomed Biotechnol       Date:  2006

7.  Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma.

Authors:  Zhi-Jun Sun; Guang-Tao Yu; Cong-Fa Huang; Lin-Lin Bu; Jian-Feng Liu; Si-Rui Ma; Wen-Feng Zhang; Bing Liu; Lu Zhang
Journal:  Oncotarget       Date:  2016-03-08

8.  An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules.

Authors:  Huaxia Qin; Michael W Y Chan; Sandya Liyanarachchi; Curtis Balch; Dustin Potter; Irene J Souriraj; Alfred S L Cheng; Francisco J Agosto-Perez; Elena V Nikonova; Pearlly S Yan; Huey-Jen Lin; Kenneth P Nephew; Joel H Saltz; Louise C Showe; Tim H M Huang; Ramana V Davuluri
Journal:  BMC Syst Biol       Date:  2009-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.